<p>Endurant™ stent graft system is designed to treat abdominal aortic aneurysms (AAA) using a minimally invasive endovascular aneurysm repair (EVAR).</p>
The Endurant™ system was designed with key features3 to address sac regression and ensure durability.4–6
Accurate placement and controlled deployment4
Intuitive graft deployment system7 offers controlled delivery at the intended target zone with 99.3% delivery and deployment success investigational device exemption (IDE).†,4
Tip capture deployment mechanism — even after deployment of three stent rings — provides gradual, controlled, and accurate deployment at the intended sealing zone.4
Deployment of the Endurant™ II stent graft
Deployment of the Endurant™ IIs stent graft
Continuous seal5
Separation of seal from fixation — with suprarenal fixation, which enables seal to occur independently.5
M-shaped proximal stents, unique to the Endurant™ stent graft, maximize wall apposition and circumferential conformability5 to minimize in-folding resulting in low type Ia endoleak rates.2
Electropolished nitinol stents maximize circumferential conformability with dynamic continuous seal.5
Resistance against type II endoleak6
Woven, high-density, multifilament polyester material8 that promotes sac thrombosis6
Addresses sac regression3–6
Decade of durability data2
Endurant™ AAA stent graft system: The first and only EVAR system with a decade of global registry outcomes.2
Endurant™ II bifurcated configuration — an aortoiliac stent graft that is available in three lengths.
Endurant™ IIs bifurcated configuration — an aortic configuration available in a single, shorter length.
Aorto-uni-iliac (AUI) main body stent graft:
The AUI device is indicated for the endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms only in patients whose anatomy does not allow the use of a bifurcated device. The proximal end of the AUI configuration is deployed into the proximal neck and upper section of the aneurysm. The proximal section of the AUI configuration is composed of nitinol stents sewn to a fabric graft.
Endurant™ II stent graft
Endurant™ IIs stent graft
Endurant™ II AUI stent graft
Ordering information
Endurant™ II bifurcations
Item number
Proximal graft diameter (mm)
Distal graft diameter (mm)
Distal design
Total covered length (mm)
Delivery system
Catheter outer diameter (Fr)
ETBF2313C124E
23
13
C
124
E
18
ETBF2313C145E
23
13
C
145
E
18
ETBF2313C166E
23
13
C
166
E
18
ETBF2316C124E
23
16
C
124
E
18
ETBF2316C145E
23
16
C
145
E
18
ETBF2316C166E
23
16
C
166
E
18
ETBF2513C124E
25
13
C
124
E
18
ETBF2513C145E
25
13
C
145
E
18
ETBF2513C166E
25
13
C
166
E
18
ETBF2516C124E
25
16
C
124
E
18
ETBF2516C145E
25
16
C
145
E
18
ETBF2516C166E
25
16
C
166
E
18
ETBF2813C124E
28
13
C
124
E
18
ETBF2813C145E
28
13
C
145
E
18
ETBF2813C166E
28
13
C
166
E
18
ETBF2816C124E
28
16
C
124
E
18
ETBF2816C145E
28
16
C
145
E
18
ETBF2816C166E
28
16
C
166
E
18
ETBF2820C124E
28
20
C
124
E
18
ETBF2820C145E
28
20
C
145
E
18
ETBF2820C166E
28
20
C
166
E
18
ETBF3216C124E
32
16
C
124
E
20
ETBF3216C145E
32
16
C
145
E
20
ETBF3216C166E
32
16
C
166
E
20
ETBF3220C124E
32
20
C
124
E
20
ETBF3220C145E
32
20
C
145
E
20
ETBF3220C166E
32
20
C
166
E
20
ETBF3616C145E
36
16
C
145
E
20
ETBF3616C166E
36
16
C
166
E
20
ETBF3620C145E
36
20
C
145
E
20
ETBF3620C166E
36
20
C
166
E
20
Endurant™ IIs bifurcations
Item number
Proximal graft diameter (mm)
Distal graft diameter (mm)
Distal design
Total covered length (mm)
Delivery system
Catheter outer diameter (Fr)
ESBF2314C103E
23
14
C
103
E
18
ESBF2514C103E
25
14
C
103
E
18
ESBF2814C103E
28
14
C
103
E
18
ESBF3214C103E
32
14
C
103
E
20
ESBF3614C103E
36
14
C
103
E
20
Limbs‡
Item number
Proximal graft diameter (mm)
Distal graft diameter (mm)
Distal design
Total covered length (mm)
Delivery system
Catheter outer diameter (Fr)
Total contralateral covered length with EII/EIIs bifurcated§
Total ipsilateral covered length with EIIs bifurcated◊
ETLW1610C82E
16
10
C
82
E
14
132
152
ETLW1610C93E
16
10
C
93
E
14
143
163
ETLW1610C124E
16
10
C
124
E
14
174
174–194
ETLW1610C146E
16
10
C
146
E
16
196
196–216
ETLW1610C156E
16
10
C
156
E
16
206
206–226
ETLW1610C199E
16
10
C
199
E
16
249
249–269
ETLW1613C82E
16
13
C
82
E
14
132
152
ETLW1613C93E
16
13
C
93
E
14
143
163
ETLW1613C124E
16
13
C
124
E
14
174
174–194
ETLW1613C146E
16
13
C
146
E
16
196
196–216
ETLW1613C156E
16
13
C
156
E
16
206
206–226
ETLW1613C199E
16
13
C
199
E
16
249
249–269
ETLW1616C82E
16
16
C
82
E
14
132
132–152
ETLW1616C93E
16
16
C
93
E
14
143
143–163
ETLW1616C124E
16
16
C
124
E
14
174
174–194
ETLW1616C146E
16
16
C
146
E
16
196
196–216
ETLW1616C156E
16
16
C
156
E
16
206
206–226
ETLW1616C199E
16
16
C
199
E
16
249
249–269
ETLW1620C82E
16
20
C
82
E
16
132
152
ETLW1620C93E
16
20
C
93
E
16
143
163
ETLW1620C124E
16
20
C
124
E
16
174
174–194
ETLW1620C146E
16
20
C
146
E
16
196
196–216
ETLW1620C156E
16
20
C
156
E
16
206
206–226
ETLW1620C199E
16
20
C
199
E
16
249
249–269
ETLW1624C82E
16
24
C
82
E
16
132
152
ETLW1624C93E
16
24
C
93
E
16
143
163
ETLW1624C124E
16
24
C
124
E
16
174
174–194
ETLW1624C146E
16
24
C
146
E
16
196
196–216
ETLW1624C156E
16
24
C
156
E
16
206
206–226
ETLW1624C199E
16
24
C
199
E
16
249
249–269
ETLW1628C82E
16
28
C
82
E
16
132
152
ETLW1628C93E
16
28
C
93
E
16
143
163
ETLW1628C124E
16
28
C
124
E
16
174
174–194
ETLW1628C146E
16
28
C
146
E
16
196
196–216
ETLW1628C156E
16
28
C
156
E
16
206
206–226
ETLW1628C199E
16
28
C
199
E
16
249
249–269
‡ The limb mates with the AUI stent graft on the ipsilateral side.
§ These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant™ II/IIs stent graft system instructions for use.
◊ The 3–5 stent overlap is available only with select limbs. Please refer to the instructions for use for more information.
† Delivery success equals successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success equals successful deployment of the device in the intended site and the successful removal of the delivery system.
‡ The limb mates with the AUI stent graft on the ipsilateral side.
§ These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant™ II/IIs stent graft system instructions for use.
◊ The 3–5 stent overlap is available only with select limbs. Please refer to the instructions for use for more information.
Based on internal Endurant™ patient implant tracking at Medtronic. Data current as of September 2023.
Verhagen. The ENGAGE Registry: Ten-year outcomes with the Endurant stent graft for endovascular abdominal aortic aneurysm repair. Presented at: Charing Cross 2023 International Symposium; April 26, 2023; London, UK.
Lalys F, Daoudal A, Gindre J, Göksu C, Lucas A, Kaladji A. Influencing factors of sac shrinkage after endovascular aneurysm repair. J Vasc Surg. 2017;65(6):1830–1838. doi:10.1016/j.jvs.2016.12.131.
Makaroun MS, Tuchek M, Massop D, et al. One year outcomes of the United States regulatory trial of the Endurant stent graft system. J Vasc Surg. 2011;54(3):601–608. doi:10.1016/j.jvs.2011.03.002.
Based on internal test report DVR7245 design verification report: Endurant stent graft system™ conducted January–July 2007.
Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. 1989;9(2):234–243. doi:10.1067/mva.1989.vs0090234.
Rouwet EV, Torsello G, de Vries J-PPM, et al. Final results of the prospective European trial of the Endurant stent graft for endovascular abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2011;42(4):489–497. doi:10.1016/j.ejvs.2011.06.008.
Based on internal materials report 10011927DOC Rev.AE.
